SCHEMBL7542538

SCHEMBL7542538

CON=C(c1cc(C)no1)c1ccccc1CO

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 5/20 0.41
▸ MEN1 O00255 4/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ HCAR2 Q8TDS4 1/20 0.36
▸ ALDH1A1 P00352 4/20 0.35
▸ USP2 O75604 2/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ TSHR P16473 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.34
▸ POLB P06746 2/20 0.33
▸ SGPL1 O95470 1/20 0.33
▸ NPC1 O15118 2/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ BRD4 O60885 1/20 0.32
▸ GLA P06280 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HIF1A Q16665 1/20 0.32
▸ PKM P14618 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7537180 0.89 KMT2A (0.41) KMT2AMEN1MAPK1HCAR2ALDH1A1
SCHEMBL7542049 0.81 RAB9A (0.42) ALDH1A1KDM4EL3MBTL1POLBNPC1
SCHEMBL7535896 0.80 MAPT (0.40) KMT2AMEN1MAPK1ALDH1A1TSHR
SCHEMBL7537476 0.76 PPARG (0.36) KMT2AMEN1POLBNPC1RAB9A
SCHEMBL7535658 0.74 MRGPRX4 (0.43) ALDH1A1KDM4EPOLBRAB9ASMN1; SMN2
SCHEMBL8444480 0.74 NPC1 (0.30) L3MBTL1SGPL1NPC1RAB9A
SCHEMBL8444479 0.74 NPC1 (0.30) L3MBTL1SGPL1NPC1RAB9A
SCHEMBL7535577 0.65 RAB9A (0.39) KMT2AMEN1MAPK1ALDH1A1KDM4E
SCHEMBL6963970 0.64 KMT2A (0.36) KMT2AMEN1MAPK1ALDH1A1USP2
SCHEMBL29037844 0.63 HIF1A (0.47) KMT2AMEN1ALDH1A1KDM4EL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6362212-B1 POTENT FUNGICIDAL ACTIVITY SHIONOGI & COMPANY, LTD. (JP) 2002-03-26 — — US disclosed
US-20020032227-A1 Oxime derivative and bactericide containing the same as active ingredient TAKASE AKIRA (JP) 2002-03-14 — — US disclosed
US-6268312-B1 FUNGICIDES SHIONOGI & CO., LTD. (JP) 2001-07-31 — — US disclosed
US-6048885-A FUNGICIDES SHIONOGI & CO., LTD. (JP) 2000-04-11 — — US disclosed
EP-0754684-A1 OXIME DERIVATIVE AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT SHIONOGI & CO., LTD. (JP) 1997-01-22 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032227-A1 Oxime derivative and bactericide containing the same as active ingredient MSMO1, O60361, CBR1 KMT2A 1852/4885MEN1 1445/4885MAPK1 1588/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback